Professional medical-grade BMI assessment with comprehensive anorexia nervosa risk evaluation, treatment recommendations, and emergency risk identification.
Enter your measurements to calculate BMI and assess anorexia risk
| BMI Range | Category | Anorexia Risk | Medical Status | Action Required |
|---|---|---|---|---|
| 25.0+ | Normal/Overweight | No Risk | Healthy Range | Maintain healthy lifestyle |
| 18.5-24.9 | Normal Weight | No Risk | Healthy Range | Continue current habits |
| 17.5-18.4 | Underweight | Low Risk | Monitor Closely | Medical consultation advised |
| 16.0-17.4 | Mild Anorexia | Mild Risk | Treatment Recommended | Eating disorder specialist |
| 15.0-15.9 | Moderate Anorexia | Moderate Risk | Intensive Treatment | Immediate professional help |
| 13.5-14.9 | Severe Anorexia | Severe Risk | Hospitalization | Inpatient treatment required |
| 12.0-13.4 | Extreme Anorexia | Critical Risk | Organ Failure Risk | Emergency medical care |
| <12.0 | Life-Threatening | Emergency | Immediate Danger | Call 911 immediately |
Anorexia nervosa is a severe, potentially life-threatening psychiatric disorder characterized by the deliberate restriction of caloric intake, resulting in significantly low body weight, intense fear of weight gain, and profound disturbances in body image perception. First clinically described by Sir William Gull in 1873, anorexia nervosa affects approximately 0.9% of women and 0.3% of men during their lifetime, with the highest prevalence occurring during adolescence and young adulthood.
The disorder transcends simple dietary restriction, involving complex neurobiological, psychological, and social factors that create a self-perpetuating cycle of starvation and cognitive distortion. Anorexia nervosa has the highest mortality rate of any psychiatric illness, with standardized mortality ratios ranging from 5.6 to 11.5, primarily due to suicide, cardiac complications, and medical consequences of malnutrition. The condition typically emerges during critical developmental periods, particularly between ages 14-18, when identity formation and body awareness are heightened.
Understanding anorexia nervosa requires recognition of its multifaceted nature, encompassing genetic predisposition (heritability estimates of 50-80%), neurobiological alterations in reward and cognitive processing, psychological vulnerabilities including perfectionism and anxiety, and sociocultural pressures emphasizing thinness. The disorder affects individuals across all demographic boundaries, though certain populations, including athletes, dancers, models, and individuals with Type 1 diabetes, face elevated risk.
The clinical understanding of anorexia nervosa has evolved significantly since its first medical documentation. William Gull's original observations of "apepsia hysterica" in Victorian England coincided with Richard Morton's descriptions of "nervous consumption" in 1689. The term "anorexia nervosa" was coined by Gull in 1888, combining the Greek "an" (without) and "orexis" (appetite) with "nervosa" indicating nervous origin, though modern understanding recognizes that appetite loss is often secondary to rigid dietary control rather than primary.
Throughout the 20th century, theoretical frameworks shifted from psychoanalytic interpretations emphasizing fear of oral impregnation and rejection of femininity to family systems models highlighting enmeshed family dynamics and overprotective parenting. Contemporary biopsychosocial models integrate genetic vulnerability, neurobiological dysfunction, psychological factors, and environmental triggers, recognizing anorexia nervosa as a complex brain-based disorder requiring comprehensive, evidence-based treatment approaches.
Advanced neuroimaging studies reveal significant structural and functional brain alterations in anorexia nervosa, involving regions critical for executive function, reward processing, body image perception, and interoceptive awareness. Gray matter reductions in the anterior cingulate cortex, insula, parietal cortex, and cerebellum correlate with symptom severity and duration of illness. These changes, while partially reversible with weight restoration, may persist years into recovery, potentially contributing to relapse vulnerability.
Neurotransmitter dysregulation involves multiple systems: serotonin alterations affecting mood, impulse control, and satiety signaling; dopamine dysfunction impacting reward processing and motivation; norepinephrine changes influencing stress response and autonomic function; and neuropeptide alterations (leptin, ghrelin, neuropeptide Y) disrupting hunger and satiety cues. These neurochemical imbalances contribute to the ego-syntonic nature of anorexic symptoms, where restrictive behaviors become increasingly valued and difficult to relinquish.
Global epidemiological data indicates anorexia nervosa prevalence of approximately 0.3-0.9% in females and 0.1-0.3% in males, with lifetime prevalence potentially reaching 4% when including subthreshold presentations. Incidence rates have shown concerning increases, particularly among adolescent populations, with peak onset occurring bimodally at ages 14-15 and 18-19. Geographic variations exist, with higher rates in Western, industrialized nations, though globalization and social media expansion have contributed to increasing prevalence in previously low-risk populations.
Female Lifetime Prevalence
Peak Onset Age Range
Cases in Females
The clinical presentation of anorexia nervosa encompasses a complex constellation of physical, psychological, behavioral, and cognitive symptoms that develop progressively as malnutrition advances. Early recognition of these symptoms is crucial for timely intervention and improved treatment outcomes. Symptoms often emerge gradually and may be initially dismissed as typical adolescent dieting behaviors or health-conscious choices.
Accurate diagnosis of anorexia nervosa requires comprehensive clinical assessment incorporating multiple domains including medical evaluation, psychological assessment, nutritional analysis, and behavioral observation. The diagnostic process must differentiate anorexia nervosa from other conditions that may present with weight loss or food restriction, including medical illnesses, other psychiatric disorders, and normal developmental variations in eating patterns.
Restriction of energy intake relative to requirements, leading to a significantly low body weight in the context of age, sex, developmental trajectory, and physical health. Significantly low weight is defined as weight that is less than minimally normal or, for children and adolescents, less than minimally expected.
Intense fear of gaining weight or becoming fat, or persistent behavior that interferes with weight gain, even though at a significantly low weight. This criterion recognizes that some individuals may not explicitly express fear but demonstrate behavior consistent with such fear.
Disturbance in the way one's body weight or shape is experienced, undue influence of body weight or shape on self-evaluation, or persistent lack of recognition of the seriousness of current low body weight.
During the last 3 months, no recurrent episodes of binge eating or purging behavior (vomiting or misuse of laxatives, diuretics, or enemas).
During the last 3 months, recurrent episodes of binge eating or purging behavior (vomiting or misuse of laxatives, diuretics, or enemas).
Treatment of anorexia nervosa requires a comprehensive, multidisciplinary approach addressing the complex interplay of medical, psychological, nutritional, and social factors that maintain the disorder. The primary goals include medical stabilization, nutritional rehabilitation, psychological recovery, and relapse prevention. Treatment intensity varies based on medical stability, psychological functioning, and environmental supports, ranging from outpatient care to intensive inpatient hospitalization.
Reserved for medical instability, severe psychological symptoms, or failed lower levels of care. Focus on medical stabilization, supervised nutrition, and initial psychological intervention.
24-hour structured environment providing comprehensive treatment including medical monitoring, nutritional rehabilitation, intensive therapy, and skill development. Typical duration 1-6 months.
Intensive day treatment program typically 6-8 hours daily, 5-7 days per week. Provides structured meals, therapy sessions, and medical monitoring while allowing return home each evening.
Step-down level of care providing 3-4 hours of treatment 3-5 days per week. Combines therapy, nutritional counseling, and meal support while maintaining community integration.
Gold standard for adolescent anorexia nervosa with strong evidence base. Three-phase approach empowering parents to take control of refeeding and weight restoration.
Transdiagnostic approach addressing core maintaining mechanisms across eating disorders. Particularly effective for adult anorexia nervosa and comorbid presentations.
Recovery from anorexia nervosa is achievable but often requires sustained treatment engagement over months to years. Outcome research demonstrates significant variability in recovery trajectories, with factors such as age at onset, duration of illness, treatment adherence, family support, and comorbid conditions significantly influencing prognosis. Understanding these factors helps inform treatment planning, family education, and realistic expectation setting for the recovery process.
Full Recovery Rate
Long-term follow-up studies
Significant Improvement
With appropriate treatment
Average Recovery Time
Variable by individual
Relapse Rate
First year post-treatment
Recovery from anorexia nervosa extends beyond simple weight restoration to encompass physical, psychological, behavioral, and social dimensions. Modern conceptualizations emphasize functional recovery alongside symptomatic improvement, recognizing that quality of life restoration is equally important to clinical symptom resolution.
Relapse prevention represents a critical component of anorexia nervosa treatment, as the disorder carries significant risk for symptom recurrence, particularly during times of stress, life transitions, or reduced treatment intensity. Comprehensive relapse prevention planning addresses both internal and external risk factors while building robust coping strategies and support systems.
While BMI below 18.5 kg/m² is considered underweight, anorexia nervosa diagnosis requires BMI significantly below normal ranges: BMI below 17.5 kg/m² in adults suggests possible anorexia nervosa. However, diagnosis involves multiple criteria including psychological factors, not just BMI. Severity classifications include: Mild (BMI ≥17), Moderate (BMI 16-16.99), Severe (BMI 15-15.99), and Extreme (BMI <15).
Important: BMI alone cannot diagnose anorexia nervosa. Professional evaluation considering psychological, behavioral, and medical factors is essential.
BMI provides a useful screening tool but has limitations. It doesn't account for muscle mass, bone density, or body composition variations. Some individuals may have anorexia nervosa with BMI in "normal" ranges, especially in early stages or atypical presentations. Additionally, BMI doesn't capture the psychological aspects crucial for diagnosis - fear of weight gain, body image distortion, and restriction behaviors.
Best Practice: Use BMI as one component of comprehensive assessment including psychological, behavioral, and medical evaluation by qualified professionals.
Yes, absolutely. "Atypical anorexia nervosa" involves all anorexia criteria except significantly low weight. Individuals may have normal or above-normal BMI while exhibiting severe restriction, weight phobia, and body image distortion. This presentation is increasingly common and equally serious, requiring the same comprehensive treatment approach as typical anorexia nervosa.
While anyone can develop anorexia nervosa, highest risk groups include: adolescent and young adult females (90-95% of cases), individuals in appearance-focused activities (dance, gymnastics, modeling), people with Type 1 diabetes (2.4x higher risk), LGBTQ+ youth, those with anxiety disorders or perfectionist traits, and individuals with family history of eating disorders.
Standard BMI Assessment
Calculate standard Body Mass Index with comprehensive category analysis, health risk assessment, and personalized recommendations for weight management.
Medical BSA Assessment
Calculate Body Surface Area using multiple validated formulas including Mosteller, DuBois, Haycock, and others for medical dosing and physiological assessments.
BAC Assessment Tool
Calculate Blood Alcohol Content using Widmark formula with real-time results, legal limit comparisons, and comprehensive alcohol safety information.
Multiple IBW Formulas
Calculate ideal body weight using Robinson, Miller, Devine, Hamwi, and Broca formulas with gender-specific adjustments and healthy weight range recommendations.
Body Composition Analysis
Estimate body fat percentage using multiple methods including skinfold measurements, BIA equations, and visual estimation with health implications and fitness recommendations.
Explore our comprehensive collection of medical-grade calculators designed by healthcare professionals to provide accurate assessments for various health metrics, body composition analysis, and clinical calculations.
View All Health CalculatorsThis Anorexic BMI Calculator is for educational and informational purposes only and is not intended to replace professional medical diagnosis or treatment. Anorexia nervosa is a complex mental health disorder that requires comprehensive evaluation by qualified healthcare professionals including physicians, psychiatrists, and eating disorder specialists. BMI alone cannot diagnose anorexia nervosa. If you or someone you know may have an eating disorder, please seek immediate professional help. This tool should not be used for self-diagnosis or to delay seeking professional medical care.